Learn more

SANOFI BIOTECHNOLOGY

Overview
  • Total Patents
    209
  • GoodIP Patent Rank
    8,405
  • Filing trend
    ⇧ 22.0%
About

SANOFI BIOTECHNOLOGY has a total of 209 patent applications. It increased the IP activity by 22.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are RETINAL SOLUTIONS LLC, HAMLET PHARMA AB and COULTER PHARM INC.

Patent filings per year

Chart showing SANOFI BIOTECHNOLOGYs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hanotin Corinne 67
#2 Bessac Laurence 66
#3 Chaudhari Umesh 49
#4 Radin Allen 49
#5 Graham Neil 36
#6 Pirozzi Gianluca 32
#7 Pordy Robert C 26
#8 Schwemmer Gipe Daniel A 26
#9 Sasiela William J 26
#10 Baccara-Dinet Marie 23

Latest patents

Publication Filing date Title
WO2021011614A1 Methods for treating or preventing asthma by administering an il-4r antagonist
WO2020252214A1 Modified dosage of subcutaneous tocilizumab for rheumatoid arthritis
WO2020247461A1 Compositions and methods for treating pain in subj ects with rheumatoid arthritis
US2021000949A1 Methods for treating or preventing asthma by administering an il-33 antagonist
US2020405851A1 Method of diagnosis and treatment of rheumatoid arthritis
TW202043285A Compositions and methods for treating juvenile idiopathic arthritis
CA3092936A1 Use of pcsk9 inhibitor for reducing cardiovascular risk
US2019169299A1 Methods for treating or preventing asthma by administering an il-4r antagonist
TW201904608A Method for treating hyperlipemia in diabetic patients by administering PCSK9 inhibitor
US2019031774A1 Methods for treating hyperlipidemia in diabetic patients by administering a pcsk9 inhibitor
HK1243716A1 Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
ZA201700195B Methods for treating patients with heterozygous familial hypercholesterolemia (hefh)
HK1225635A1 Compositions for the treatment of rheumatoid arthritis and methods of using same
SG10202004083UA Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same
CA3003874A1 Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same
EP3216461A1 Compositions and methods for treating rheumatoid arthritis
MX2017006286A Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist.
CA2955294A1 Methods for treating patients with heterozygous familial hypercholesterolemia (hefh)
WO2016011260A1 Methods for treating high cardiovascular risk patients with hypercholesterolemia
EP3770173A1 Compositions for the treatment of rheumatoid arthritis and methods of using same